Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AG-OSELTAMIVIR DIN 02510251

Status: Approved
Holder: ANGITA PHARMA INC.
Molecule: OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

Health Canada record

Active ingredient(s)OSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AH02 OSELTAMIVIR
Original market date
Current status date23-Aug-2023
SourceHealth Canada DPD

Establishment licence of the holder

Angita Pharma Inc. — licence 101870, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

DINProductCompanyFormStrengthStatus
02536919ACH-OSELTAMIVIR PHOSPHATEACCORD HEALTHCARE INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGApproved
02536900ACH-OSELTAMIVIR PHOSPHATEACCORD HEALTHCARE INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGApproved
02536897ACH-OSELTAMIVIR PHOSPHATEACCORD HEALTHCARE INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGApproved
02510278AG-OSELTAMIVIRANGITA PHARMA INC.CapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGApproved
02510286AG-OSELTAMIVIRANGITA PHARMA INC.CapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGApproved
02497417JAMP OSELTAMIVIRJAMP PHARMA CORPORATIONCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGApproved
02497409JAMP OSELTAMIVIRJAMP PHARMA CORPORATIONCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02497425JAMP OSELTAMIVIRJAMP PHARMA CORPORATIONCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02497441MINT-OSELTAMIVIRMINT PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02497476MINT-OSELTAMIVIRMINT PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02497468MINT-OSELTAMIVIRMINT PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGApproved
02472643NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGMarketed
02499894NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 6 MGMarketed
02457989NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02472635NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02509962OSELTAMIVIR POWDER FOR ORAL SUSPENSIONSTRIDES PHARMA CANADA INCPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 6 MGApproved
02504006SANDOZ OSELTAMIVIRSANDOZ CANADA INCORPORATEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02504022SANDOZ OSELTAMIVIRSANDOZ CANADA INCORPORATEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02504014SANDOZ OSELTAMIVIRSANDOZ CANADA INCORPORATEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGMarketed
02304848TAMIFLUHOFFMANN-LA ROCHE LIMITEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02304856TAMIFLUHOFFMANN-LA ROCHE LIMITEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGMarketed
02381842TAMIFLUHOFFMANN-LA ROCHE LIMITEDPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 6 MGMarketed
02241472TAMIFLUHOFFMANN-LA ROCHE LIMITEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02497379MAR-OSELTAMIVIRMARCAN PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGCancelled Post Market
02497352MAR-OSELTAMIVIRMARCAN PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGCancelled Post Market
02497360MAR-OSELTAMIVIRMARCAN PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGCancelled Post Market
02478420MYLAN-OSELTAMIVIRMYLAN PHARMACEUTICALS ULCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGCancelled Pre Market
02478439MYLAN-OSELTAMIVIRMYLAN PHARMACEUTICALS ULCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGCancelled Pre Market
02478412MYLAN-OSELTAMIVIRMYLAN PHARMACEUTICALS ULCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGCancelled Pre Market
02245549TAMIFLU ORAL SUSPENSIONHOFFMANN-LA ROCHE LIMITEDPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 12 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
249532021-01-07Abbreviated New Drug Submission (ANDS)LICENSING AGREEMENT BETWEEN TWO COMPANIES
Request a quote for AG-OSELTAMIVIR

How to read a Canadian DIN record